Perspective Therapeutics, Inc. (CATX)
4.71
+0.08
(+1.73%)
USD |
NYAM |
Feb 06, 16:00
4.66
-0.05
(-1.06%)
After-Hours: 20:00
Perspective Therapeutics SG&A Expense (TTM) : 31.53M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Outset Medical, Inc. | 92.14M |
| Abbott Laboratories | 12.33B |
| Accuray, Inc. | 88.55M |
| Alphatec Holdings, Inc. | 484.37M |
| Plus Therapeutics, Inc. | 11.09M |